In addition to Sifuvirtide, FusoGen has been developing new drugs for hepatitis B and hepatitis C, using its proprietary platform of computer drug design.

• 继西夫韦肽研制成功之后，扶素生物应用自有的计算机药物设计平台，设计出抗乙肝病毒和丙肝病毒的抑制剂。